The 7th annual European Patients as Partners in Clinical Research conference is back in person. The conference offers an unparalleled opportunity to hear from pharma R&D and patient advocacy together on how patient involvement gets done to drive greater efficiencies in clinical research with better outcomes. The conference prioritizes the patient voice for the R&D industry to learn how we can increase diverse representation, connect with a wide range of patient communities, make finding clinical research easier for patients and physicians and how we can give useful data back to patients. Experts from Novartis, Sanofi, GSK, CSL Behring, Servier, Boehringer Ingelheim, Lundbeck, Alnylam Pharmaceuticals, Ipsen and more will gather with patient advocacy to address The evolution of patient informed research, Increasing diversity in clinical research, Patient access to research through digital innovation, Understanding barriers to community engagement in clinical research, Turning patient insights into action, Navigating patient engagement and compliance, Mapping and how to measure patient engagement and Regulatory requirements and patient engagement in drug development.

Read on theconferenceforum.org

Our mission is to showcase the most exciting investment opportunities in the sector and connect those businesses with financial investors and strategic corporate partners.

Alongside our investment pitches, we include keynote presentations and host CEO-level panel discussions that address the most pressing trends and market dynamics of the animal health, nutrition, and technology industries, across all species.

The Innovation Showcase Returns for 2023!

The showcase is a unique opportunity for emerging companies with amazing technology to present in front of the industry's most influential figures and investors. 20 start-ups, hand-picked by the Selection Committee, introduce themselves, their innovations and achievements on the main stage. This year, our finalists will be presenting products across health, nutrition and technology areas, taking part in either the companion showcase or production showcase. 

Read on go.evvnt.com

The World Medical Innovation Forum is a global conference of more than 1,700 health care leaders in the heart of Boston. Join us in person at the World Medical Innovation Forum as we bring together global leaders to assess the latest opportunities and challenges, from the investment landscape to key technology developments to manufacturing and regulatory barriers. Gain first-hand insights on medicine’s ultimate game changer.

Read on worldmedicalinnovation.org

As Medicare and other healthcare payers experiment with alternative payment models, the pressure is building on hospitals and healthcare systems, as well as post-acute care and outpatient providers, to deliver care in a more efficient way while improving patient outcomes. Among the most important issues in alternative payment models are hospital readmissions readmissions are expensive, a metric of poor-quality care, and often a sign of poor downstream functional outcomes. However, many readmissions are potentially preventable. The Hospital Readmission Reduction Program implemented by CMS reduces payments to acute care facilities with a high 30-day readmission rate. The key to keeping 30-day readmission rates low is preventing potentially avoidable hospitalizations by improving transitions of care and by providing effective primary care interventions. Keeping patients healthy and ensuring timely follow-up is paramount to preventing readmissions. Providers also need to ensure that the correct discharge orders for follow-up care are carried out. Additionally, including the patients and their families in the decision-making will lead to better understanding and hopefully better outcomes.

This conference will bring together healthcare leaders to highlight successful hospital strategies that reduce hospital readmissions, including improved discharge processes; successful reduction strategies for hospital acquired infections; patient safety; the impact of social determinants of health; reducing healthcare-associated infections; health IT solutions, artificial intelligence and digital health; optimizing transitions of care; the role of community partnerships; patient engagement strategies; providing palliative care across the continuum; health equity; payer-provider collaborations and more.

Read on brinetwork.com

Meeting patients’ needs and improving financial performance have become major focus areas for hospital and health system executives facing payment pressures and the market shift towards patient-centered and value-based care. And as patients increasingly shop for healthcare services, enhancing patient experience is regarded as a potential driver of hospital performance, since it may build reputation and brand, strengthen customer loyalty, and boost utilization of hospital services through increased referrals to family and friends. In addition, hospitals’ reimbursements from private insurers and Medicare are increasingly tied to quality performance metrics that capture patient experience as well as clinical outcomes. And improving patient experience is one of the fundamental concepts underlying the Triple Aim approach to optimizing health system performance. And overall, good patient experience is an important outcome unto itself, as patients intrinsically value the interpersonal aspects of the clinician-patient relationship, such as compassion, communication, and an overall sense of being treated with dignity and respect.

This conference will explore how good patient experience is associated with higher hospital profitability and better care. Learn mechanisms through which patient experience can improve financial performance and patient-centered care and understand why patient experience is now nationally – and globally – recognized as an independent dimension of healthcare quality. Gain insights from sessions that will dive into topics such as how to improve patient experience in the emergency department, engaging physicians, how to leverage technology, driving a strong patient experience culture, digitization, team-based care, communication strategies, patient journey mapping, and more.

Read on brinetwork.com

Digital health is the intersection between technology and healthcare, and it is playing and increasingly important role in healthcare today and is a central focus for hospitals, health systems and health plans. Advances in artificial intelligence, big data, robotics, machine learning, smart phones, social networks, and internet applications continue to bring about major changes in digital healthcare. The use of these technologies is not only changing the way we communicate, but also giving providers a more holistic view of patient health through access to data and giving patients more control over their health.

Digital healthcare has the potential to prevent disease and lower healthcare costs, while helping patients monitor and manage chronic conditions, and better manage and track their health and wellness-related activities. Healthcare providers also can benefit greatly from advances in digital healthcare. Digital tools give providers an extensive view of a patient’s health by significantly increasing access to data. The result is increased efficiency and improved medical outcomes. This conference will explore ways in which providers can embrace this revolution and leverage digital healthcare to facilitate prevention and early diagnosis of life-threatening diseases, manage chronic conditions outside of the traditional healthcare settings, reduce inefficiencies, improve access, reduce costs, increase quality, and make healthcare more personalized for patients.

Read on brinetwork.com

Breast Cancer Summit 2023 invites individuals from the entire world to participate at the 13th World Congress on Breast Cancer Research & Therapies during June 12-13, 2023 in Melbourne, Australia which incorporates Keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme for the conference this year is Visualizing the novel diagnostic approaches of Breast Cancer guarantees an exceptional logical program including some notable and interesting speakers. Breast Cancer is the strange development of the cells coating the breast lobules or channels. These cells develop wildly and can possibly spread to different pieces of the body. All kinds of people can foster breast malignancy, even though it is phenomenal in men.
Read on breastcancer.cancersummit.org

The 2023 In Vitro Biology Meeting will be held from Saturday, June 10 – Tuesday, June 14, 2023, in Norfolk, Virginia at the Hilton Norfolk The Main. The Program Committee is preparing a schedule of symposia, workshops, contributed paper, interactive poster, and poster sessions that will highlight the most recent advances in the plant and animal biotechnology and genomics. Sessions begin on Saturday, June 10 and run through Wednesday, June 14, in addition plans are underway for Wednesday scientific tours. SIVB offers numerous opportunities for students and Post-Docs such as competitions, focused workshops and meetings, discounted Post-Doc registration, and, through our Student Initiative, free student registration to attend the meeting. Abstract submission will be available for you to submit your work for consideration in one of the numerous contributed paper, interactive poster, and poster sessions, including virtual poster opportunities.

Read on sivb.org

The 2023 Gordon Research Seminar on Cancer Nanotechnology (GRS) will be held in Waterville Valley, NH. The Cancer Nanotechnology GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators. The third Gordon Research Seminar on Cancer Nanotechnology will bridge nanotechnology research with translational pre-clinical cancer research. Graduate students, post-docs, and other early-career scientists will have the chance to present their cutting-edge ideas and unpublished data, as well as network with peers in an engaging environment. Nanotechnology offers exciting opportunities in the battle against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. The 2023 GRS will provide an overview of emerging cancer-related nanotechnologies from the bench to the bedside. By bringing together exceptional scientists representing clinical, biological, and physical sciences, we will gain new insights into the interface of bio-nano science and cancer nanotechnology.

Read on:grc.org/cancer-nanotechnology-grs

As the largest congress in our field worldwide, the EAACI annual meeting will again become the converging point for the allergy and clinical immunology to discuss the latest discoveries in our field, through an interactive and extensive scientific programme tailored around the motto "Pathways from precision medicine to personalised health-care in Allergy and Asthma ".

We anticipate excellent discussions around a thought-provoking scientific programme, presenting the latest findings in our field: a multitude of session types and tracks, cutting-edge abstracts on the most current research and a variety of social opportunities for interaction and networking. New activities carried out by EAACI will also be unveiled at the congress, such as new and updated guidelines, exciting plans for our Knowledge Hub, EAACI-lead initiatives in research and our entire meetings pipeline.

We encourage you to secure your participation, making use of the advantageous rates and membership discounts at your disposal, submitting your research to the Annual Congress 2023, and sharing the event among your networks. Your attendance is what makes our Annual Congress international, vibrant, scientifically rich, and a success every time.

Read on eaaci.org